VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 712 filers reported holding VANECK VECTORS ETF TR in Q4 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $592,121 | -53.7% | 22,004 | -48.2% | 0.04% | -51.6% |
| Q2 2023 | $1,279,475 | -7.3% | 42,493 | -0.4% | 0.09% | -7.1% |
| Q1 2023 | $1,380,095 | +45.2% | 42,661 | +28.6% | 0.10% | +34.2% |
| Q4 2022 | $950,789 | +100.6% | 33,174 | +68.9% | 0.07% | +82.5% |
| Q3 2022 | $474,000 | -8.8% | 19,638 | +3.3% | 0.04% | -2.4% |
| Q2 2022 | $520,000 | -40.4% | 19,005 | -16.5% | 0.04% | -30.5% |
| Q1 2022 | $873,000 | +35.6% | 22,757 | +13.2% | 0.06% | +40.5% |
| Q4 2021 | $644,000 | +5.9% | 20,111 | +12.5% | 0.04% | -12.5% |
| Q2 2021 | $608,000 | +37.2% | 17,881 | +31.3% | 0.05% | +11.6% |
| Q1 2021 | $443,000 | -16.4% | 13,618 | -7.5% | 0.04% | -21.8% |
| Q4 2020 | $530,000 | +31.2% | 14,726 | +42.6% | 0.06% | +77.4% |
| Q3 2020 | $404,000 | -73.5% | 10,327 | -75.2% | 0.03% | -86.5% |
| Q2 2020 | $1,527,000 | +61.9% | 41,623 | +29.2% | 0.23% | +93.3% |
| Q4 2019 | $943,000 | – | 32,206 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |